The transfer of data

The introduction of the possibility of transferring data from non-profit studies for registration purposes has represented a real revolution in the field of academic research and yet, more than a year after the entry into force of the Decree of Ministry of Health 30 November 2021, there is a number of outstanding problems. Read more
Psp and health App

Patient Support Programs (PSP) are programs aimed at increasing patients’ compliance with a specific therapy and are increasingly delivered in a digital version, through software made available on apps or other platforms. But how is the digital PSP regulated and what distinguishes it from other health apps? What are the tools to guarantee the patient’s […]
The synthetic Data

With the creation of synthetic data, the last outpost of the materiality of personal data is overcome: a brief look at the opportunities and risks of its use (also) in the field of biomedical research. Read more
Sponsor’s liability for the breach of the right to self-determination. Informed consent in clinical trials.

Informed consent is as an expression of the individual’s right to self-determination and it plays a key role in the context of clinical trials. Generally, the duty to obtain patient’s consent for the submission to the experimental protocol belongs to the medical staff of the health facility where the patient is being treated. However, the […]
Personal data processing for clinical research purposes: a call to action

The balance between the needs of scientific progress, the right to health and the right to the protection of personal data represents, today more than ever, a crucial challenge for the legislator and for the regulatory authorities, called to overcome “taboos” and rigidly formalistic approaches and to identify solutions that are both innovative and true […]
Clinical Trials Decree 30.11.2021. The transfer of data and results for registration purposes. Spilt between the “scientific” property and the intellectual property?

The article analyses the news on the field of non-profit clinical trials after the adoption of the Ministerial Decree on Health 30/11/2021, implementing the so-called Lorenzin Law. In particular, we will focus on two relevant and most problematic aspects. First of all the issues concerning the transfer of data and results of ab origine non-profit […]
The individual’s right to be forgotten as a “patient”

In the last years, some former cancer communities have claimed for the right to be forgotten as a “patient” as the right not to disclose one’s past pathology after a reasonable period has passed since treatment ended. But what exactly is the right to be forgotten and how is it applied in the health field? […]
PSP and data protection: the privacy governance system

The spread of Patient Support Programs (PSP) has challenged the proper allocation of privacy-related roles and responsibilities among the pharma company, the PSP provider and the health facility. To grasp the correct framework of privacy governance, the EDPB Guidelines n. 07/2020 on the concepts of Controller and Processor in the GDPR suggests to not consider […]